/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

SCYNEXIS Inc Share Price Today: Live Updates & Key Insights

SCYNEXIS Inc share price today is $0.9323, up 4.28%. The stock opened at $0.91 against the previous close of $0.894, with an intraday high of $0.9332 and low of $0.9099.

SCYNEXIS Inc Share Price Chart

style
pb-0

SCYNEXIS Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

SCYNEXIS Inc Share Price Performance

$0.9323 0.0428(4.28%) SCYX at 23 Mar 2026 03:09 PM Drug Manufacturers - Specialty & Generic
Lowest Today 0.9099
Highest Today 0.9332
Today’s Open 0.91
Prev. Close 0.894
52 Week High 1.31
52 Week Low 0.57
Day’s Range: Low 0.9099 High 0.9332
52-Week Range: Low 0.57 High 1.31
1 day return -
1 Week return +1.65
1 month return +17.53
3 month return +47.87
6 month return -17.03
1 year return -11.84
3 year return -54.16
5 year return -89.47
10 year return -

SCYNEXIS Inc Institutional Holdings

Avidity Partners Management LP 4.78

Vanguard Group Inc 4.05

Federated Hermes Inc 3.64

Vanguard Total Stock Mkt Idx Inv 2.63

Geode Capital Management, LLC 1.03

Acadian Asset Management LLC 0.96

Vanguard Institutional Extnd Mkt Idx Tr 0.88

Vifag 2002 SICAV 0.80

BlackRock Inc 0.77

AMH Equity Ltd 0.56

Fidelity Extended Market Index 0.52

Yakira Capital Management, Inc. 0.44

Renaissance Technologies Corp 0.40

Bridgeway Capital Management, LLC 0.38

GSA Capital Partners LLP 0.37

EA Bridgeway Omni Small-Cap Value ETF 0.28

Empowered Funds, LLC 0.28

State Street Corp 0.28

Citadel Advisors Llc 0.24

WEALTH EFFECTS LLC 0.21

Blackrock Extended Mkt Fund CF 0.19

Nierenberg Investment Management Co 0.17

NT Ext Equity Mkt Idx Fd - L 0.17

Extended Equity Market Fund K 0.16

Fidelity Total Market Index 0.15

Spartan Extended Market Index Pool F 0.12

UBS Group AG 0.12

Fidelity Series Total Market Index 0.12

Susquehanna International Group, LLP 0.12

LPL Financial Corp 0.11

Northern Trust Corp 0.10

Northern Trust Extended Eq Market Idx 0.10

Bridgeway Ultra-Small Company Market 0.09

Spartan Total Market Index Pool G 0.07

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.07

Vanguard Instl Ttl Stck Mkt Idx Tr 0.06

Fidelity Nasdaq Composite Index 0.05

State St US Extended Mkt Indx NL Cl C 0.02

Extended Equity Market Fund M 0.02

Vanguard U.S. Eq Idx £ Acc 0.02

SCYNEXIS Inc Market Status

Strong Buy: 2

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

SCYNEXIS Inc Fundamentals

Market Cap 41.64 M

PB Ratio 0.8433

PE Ratio 0.0

Enterprise Value 3.78 M

Total Assets 59.03 M

Volume 332200

SCYNEXIS Inc Company Financials

Annual Revenue FY23:135868000 135.9M, FY22:5091000 5.1M, FY21:13163000 13.2M, FY20:0 0.0M, FY19:121000 0.1M

Annual Profit FY23:134732000 134.7M, FY22:4463000 4.5M, FY21:12851000 12.9M, FY20:null 0.0M, FY19:121000 0.1M

Annual Net worth FY23:72198000 72.2M, FY22:-62809000 -62.8M, FY21:-32866000 -32.9M, FY20:-55185000 -55.2M, FY19:-55234000 -55.2M

Quarterly Revenue Q3/2025:334000 0.3M, Q2/2025:1364000 1.4M, Q1/2025:257000 0.3M, Q3/2024:660000 0.7M, Q2/2024:736000 0.7M

Quarterly Profit Q3/2025:334000 0.3M, Q2/2025:1364000 1.4M, Q1/2025:257000 0.3M, Q3/2024:660000 0.7M, Q2/2024:736000 0.7M

Quarterly Net worth Q3/2025:-8591000 -8.6M, Q2/2025:-6885000 -6.9M, Q1/2025:-5391000 -5.4M, Q3/2024:-2808000 -2.8M, Q2/2024:-14458000 -14.5M

About SCYNEXIS Inc & investment objective

Company Information SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Organisation Drug Manufacturers - Specialty & Generic

Employees 18

Industry Drug Manufacturers - Specialty & Generic

CEO Dr. David Gonzalez Angulo M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

SCYNEXIS Inc FAQs

What is the share price of SCYNEXIS Inc today?

The current share price of SCYNEXIS Inc is $0.9323.

Can I buy SCYNEXIS Inc shares in India?

Yes, Indian investors can buy SCYNEXIS Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy SCYNEXIS Inc shares in India?

You can easily invest in SCYNEXIS Inc shares from India by:

Can I buy fractional shares of SCYNEXIS Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of SCYNEXIS Inc?

SCYNEXIS Inc has a market cap of $41.64 M.

In which sector does SCYNEXIS Inc belong?

SCYNEXIS Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in SCYNEXIS Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of SCYNEXIS Inc?

The PE ratio of SCYNEXIS Inc is N/A and the PB ratio is 0.84.